Home > > > Report Detail

Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End User - Global Forecast to 2029

Publisher Name :
Date: 30-Nov-2023
No. of pages: 378
Inquire Before Buying

“The global transdermal patches market is projected to reach 8.0 USD Billion by 2029 from USD 6.2 Billion in 2023, at a CAGR of 4.5% from 2023 to 2029.”

The global transdermal patches market is projected to reach 8.0 USD Billion by 2029 from USD 6.2 Billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The factors driving the growth of the global transdermal patches market include the rising prevalence of chronic diseases, the expanding use of analgesic patches, technological advancements in transdermal patches, and the shift from traditional injections to transdermal patches. Nonetheless, during the anticipated period, factors such as drug failures, recalls of transdermal drug delivery systems, and increasing healthcare facility expenses will probably constrain market expansion to some degree.

“The matrix patches segment is expected to grow with the highest CAGR in patch type of the transdermal patches market.”

Due to a number of characteristics that increase the patch's appeal and efficacy, the matrix patches segment is expected to grow at the highest CAGR in the transdermal patch market. In matrix patches, the medicine is evenly dispersed within a polymer matrix, providing a straightforward but effective design. This design promotes the best possible drug absorption via the skin by enabling a prolonged, regulated release of the medicinal substance. Due to its adaptability, matrix patches are widely used in a variety of therapeutic fields. This is because they may be used to administer a broad range of drugs. Patient compliance and matrix patch efficacy are increasing as a result of ongoing technological improvements in matrix patch formulation and manufacturing.

“The silicone adhesives segment is expected to grow with the highest CAGR in the adhesive type of the transdermal patches market.”

Since silicone adhesives have particular advantages over other adhesives, it is expected that the silicone adhesive patches segment of the transdermal patch market will grow at the fastest CAGR. Silicone adhesives ensure patient comfort and adherence by forming a thin yet strong connection with the skin. Because they are biocompatible and hypoallergenic, they can be used by a wide range of patients with less chance of skin sensitivity or irritation. Silicone adhesive patches' conformability and flexibility make them more comfortable to wear and encourage prolonged and regular use.

“Based on the Application Type, the pain management segment is expected to grow by the highest CAGR in the transdermal patches market.”

The market for transdermal patches is expected to grow at the fastest rate in the pain management segment due to the growing need for safe, non-invasive pain reduction options. Pain-relieving transdermal patches deliver an even and steady therapeutic impact by releasing analgesic drugs through the skin in a targeted and regulated manner. This method offers an alternative to invasive therapies and conventional oral drugs, making it especially tempting to people with chronic pain disorders.

“Based on the Distribution Channel, The online Pharmacies segment is expected to grow with the highest CAGR in the transdermal patches market.”

As a distribution channel for transdermal patches, the online pharmacies segment is anticipated to grow at the fastest rate in the market. This is due to the general trend of digitalization and the growing dependence of healthcare items on e-commerce platforms. Customers can get transdermal patches easily and conveniently from the comfort of their homes with the help of online pharmacies. The increasing popularity of e-commerce, together with its convenient ordering and doorstep delivery features, corresponds with the changing needs of patients who want hassle-free access to healthcare.

“Based on the End User, The Homecare Settings segment is expected to grow with the highest CAGR in the transdermal patches market.”

Given the growing trend towards patient-centered and personalized healthcare, the transdermal patch market's homecare settings sector is expected to grow at the fastest rate as an end-user. For self-administration in domestic settings, transdermal patches are especially well-suited since they offer a convenient and non-invasive way to administer medication. The need for accessible, long-term treatment alternatives is fueled by the aging population and the rise of chronic illnesses. Transdermal patches are a perfect fit with this new paradigm in healthcare since homecare settings provide people the freedom to take care of their healthcare needs on their own.

“Asia Pacific to grow with the highest CAGR in the transdermal patches market during the forecast period.”

The transdermal patch market in Asia Pacific is expected to grow at the highest CAGR due to an array of factors that highlight the region's changing healthcare landscape. Transdermal patches are becoming more and more popular due to the rising incidence of chronic illnesses and rising knowledge of non-invasive medication delivery techniques. The huge and aging population in the area is a major factor in the rising cost of healthcare, which in turn is driving up demand for accessible and patient-friendly treatment choices. The transdermal patch market in Asia Pacific is also expected to rise as a result of breakthroughs in pharmaceutical research and development, rising disposable incomes, and improved healthcare infrastructure.

A breakdown of the primary participants (supply-side) for the transdermal patches market referred to for this report is provided below:


  • By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3–25%

  • By Designation: C-level–42%, Director Level–29%, and Others–29%

  • By Region: North America–30%, Europe–25%, Asia Pacific–30%, Latin America- 10%, Middle East & Africa-5%


The prominent players in the transdermal patches market include Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Luye Pharma Group (China), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), AdhexPharma (France), Evernow (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Alvogen Group Inc. (U.S.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Nitto Denko Corporation (Japan), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Endo International plc. (Ireland),  LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.).

Research Coverage:

The market study covers the transdermal patches market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by patch type, adhesive type, application, distribution type, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall transdermal patches market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:


  • Analysis of key drivers (Increasing prevalence of chronic diseases, Growing adoption of analgesic patches, Technological advancements in transdermal patches, Switching from conventional needle injections to transdermal patches), restraints (High procedural cost of vascular surgeries and associated products, Drug failure and recalls of transdermal drug delivery systems, Rising cost of healthcare facilities), opportunities (Collaborations between pharmaceutical companies and drug delivery firms, Self-administration and home care drug delivery systems) and challenges (Technical barriers related to skin irritation and permeability, Lack of skilled professionals)

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global transdermal patches market. The report analyzes this market by patch type, adhesive type, application, distribution channel, end-user, and region.

  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global transdermal patches market.

  • Market Development: Comprehensive information on the lucrative emerging markets by patch type, adhesive type, application, distribution channel, end-user, and region.

  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global transdermal patches market.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global transdermal patches market.

Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End User - Global Forecast to 2029

Table Of Contents

1 Introduction 26
1.1 Study Objectives 26
1.2 Market Definition 27
1.3 Market Scope 27
1.3.1 Inclusions And Exclusions Of Study 27
1.3.2 Markets Covered 28
1.3.3 Years Considered 28
1.4 Currency 29
Table 1 Standard Currency Conversion Rates 29
1.5 Stakeholders 29
1.6 Recession Impact 29

2 Research Methodology 30
2.1 Research Data 30
Figure 1 Research Design 30
2.1.1 Secondary Data 31
2.1.1.1 Key Data From Secondary Sources 32
2.1.2 Primary Data 33
Figure 2 Primary Sources 33
2.1.2.1 Key Data From Primary Sources 34
2.1.2.2 Key Industry Insights 34
Figure 3 Breakdown Of Primary Interviews: Supply-Side And Demand-Side Participants 35
Figure 4 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region 35
Figure 5 Breakdown Of Primary Interviews (Demand Side): By End User, Designation, And Region 36
2.2 Market Size Estimation 36
Figure 6 Supply-Side Market Size Estimation: Revenue Share Analysis 37
Figure 7 Revenue Share Analysis Illustration: Johnson & Johnson 37
Figure 8 Supply-Side Market Size Estimation: Transdermal Patches Market (2022) 38
Figure 9 Bottom-Up Approach 39
Figure 10 Top-Down Approach 39
Figure 11 Cagr Projections From Drivers, Restraints, Opportunities, And Challenges (2023–2029) 40
Figure 12 Cagr Projections: Supply-Side Analysis 41
2.3 Market Breakdown And Data Triangulation 41
Figure 13 Data Triangulation Methodology 42
2.4 Market Share Estimation 43
2.5 Assumptions For Study 43
2.6 Research Limitations 43
2.6.1 Scope-Related Limitations 43
2.6.2 Methodology-Related Limitations 44
2.7 Risk Assessment 44
Table 2 Risk Assessment: Transdermal Patches Market 44
2.8 Impact Of Recession On Transdermal Patches Market 45

3 Executive Summary 46
Figure 14 Transdermal Patches Market, By Patch Type, 2023 Vs. 2029 (Usd Million) 46
Figure 15 Transdermal Patches Market, By Adhesive Type, 2023 Vs. 2029 (Usd Million) 47
Figure 16 Transdermal Patches Market, By Application, 2023 Vs. 2029 (Usd Million) 47
Figure 17 Transdermal Patches Market, By Distribution Channel, 2023 Vs. 2029 (Usd Million) 48
Figure 18 Transdermal Patches Market, By End User, 2023 Vs. 2029 (Usd Million) 49
Figure 19 Geographical Snapshot Of Transdermal Patches Market 50

4 Premium Insights 51
4.1 Transdermal Patches Market Overview 51
Figure 20 Rising Prevalence Of Chronic Diseases To Drive Market 51
4.2 Asia Pacific: Transdermal Patches Market, By Patch Type And Country (2022) 52
Figure 21 Drug-In-Adhesive Patches Segment Accounted For Largest Market Share In 2022 52
4.3 Transdermal Patches Market: Geographic Growth Opportunities 53
Figure 22 China To Register Highest Growth During Forecast Period 53
4.4 Transdermal Patches Market, Regional Mix, 2021−2029 53
Figure 23 North America Will Continue To Dominate Transdermal Patches Market During Forecast Period 53
4.5 Transdermal Patches Market: Developing Vs. Developed Markets 54
Figure 24 Developing Markets To Register Higher Growth During Forecast Period 54

5 Market Overview 55
5.1 Introduction 55
5.2 Market Dynamics 55
Figure 25 Transdermal Patches Market: Drivers, Restraints, Opportunities, And Challenges 55
5.2.1 Drivers 56
5.2.1.1 Increasing Prevalence Of Chronic Diseases 56
5.2.1.2 Growing Adoption Of Analgesic Patches 56
5.2.1.3 Technological Advancements In Transdermal Patches 56
5.2.1.4 Switching From Conventional Needle Injections To Transdermal Patches 57
5.2.2 Restraints 57
5.2.2.1 High Procedural Cost Of Transdermal Surgeries And Associated Products 57
5.2.2.2 Drug Failure And Recalls Of Transdermal Drug Delivery Systems 57
5.2.2.3 Rising Cost Of Healthcare Facilities 58
5.2.3 Opportunities 58
5.2.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms 58
5.2.3.2 Self-Administration And Home Care Drug Delivery Systems 59
5.2.4 Challenges 59
5.2.4.1 Technical Barriers Related To Skin Irritation And Permeability 59
5.2.4.2 Lack Of Skilled Professionals 60
5.3 Technology Analysis 60
5.4 Industry Trends 60
5.4.1 Advancements In Transdermal Drug Delivery Systems 60
5.5 Value Chain Analysis 61
Figure 26 Transdermal Patches Market: Value Chain Analysis 61
5.6 Supply Chain Analysis 62
Figure 27 Transdermal Patches Market: Supply Chain Analysis 63
5.7 Trade Analysis 63
5.7.1 Trade Analysis For Transdermal Patches 63
Table 3 Import And Export Data For Transdermal Patches, By Country, 2022 63
5.8 Porter’s Five Forces Analysis 64
Table 4 Transdermal Patches Market: Porter’s Five Forces Analysis 64
5.8.1 Threat Of New Entrants 64
5.8.2 Threat Of Substitutes 64
5.8.3 Bargaining Power Of Buyers 64
5.8.4 Bargaining Power Of Suppliers 65
5.8.5 Intensity Of Competitive Rivalry 65
5.9 Tariff And Regulatory Landscape 65
5.9.1 Regulatory Analysis 65
5.9.1.1 North America 65
5.9.1.1.1 Us 65
5.9.1.1.2 Canada 65
5.9.1.2 Europe 65
5.9.1.3 Asia Pacific 66
5.9.1.3.1 China 66
5.9.1.3.2 Japan 66
5.9.1.3.3 India 66
5.9.1.4 Latin America 66
5.9.1.4.1 Brazil 66
5.9.1.4.2 Mexico 66
5.9.1.5 Middle East 67
5.9.1.6 Africa 67
5.9.2 Regulatory Bodies, Government Agencies, And Other Organizations 67
Table 5 North America: Regulatory Bodies, Government Agencies, And Other Organizations 67
Table 6 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 68
Table 7 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations 68
Table 8 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations 68
Table 9 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations 69
5.10 Patent Analysis 69
5.10.1 Patent Publication Trends For Transdermal Patches 69
Figure 28 Patent Publication Trends (January 2015–December 2022) 69
5.10.2 Jurisdiction Analysis: Top Applicants For Patents In Transdermal Patches Market 70
Figure 29 Top Applicants & Owners (Companies/Institutes) For Transdermal Patch Patents (January 2015–December 2022) 70
Figure 30 Top Applicant Countries/Regions For Transdermal Patches (January 2015–April 2022) 71
5.11 Pricing Analysis 71
Table 10 Average Selling Price Trends Of Key Players, By Application 72
Table 11 Regional Pricing Analysis Of Transdermal Patches, 2023 (Usd) 73
5.12 Key Conferences & Events In 2023–2024 74
Table 12 Transdermal Patches Market: Detailed List Of Conferences & Events 74
5.13 Key Stakeholders & Buying Criteria 75
5.13.1 Key Stakeholders In Buying Process 75
Figure 31 Influence Of Stakeholders On Buying Process Of Transdermal Patches 75
Table 13 Influence Of Stakeholders On Buying Process Of Transdermal Patches 75
5.13.2 Buying Criteria 75
Figure 32 Key Buying Criteria For Transdermal Patches 75
Table 14 Key Buying Criteria For Transdermal Patches 76
5.14 Ecosystem/Market Map 76
Figure 33 Transdermal Patches Market: Ecosystem/Market Map 76
5.15 Adjacent Market Analysis 77
Figure 34 Transdermal Patches Market: Adjacent Markets 77
5.16 Trends/Disruptions Impacting Customer’s Business 77
Figure 35 Trends/Disruptions Impacting Customer’s Business 78
5.17 Unmet Needs 78

6 Transdermal Patches Market, By Patch Type 79
6.1 Introduction 80
Table 15 Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 80
6.2 Drug-In-Adhesive Patches 80
Table 16 Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 81
Table 17 Drug-In-Adhesive Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 81
6.2.1 Single-Layer Drug-In-Adhesive Patches 82
6.2.1.1 Used To Deliver Wide Range Of Medications 82
Table 18 Single-Layer Drug-In-Adhesive Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 82
6.2.2 Multi-Layer Drug-In-Adhesive Patches 83
6.2.2.1 Enhanced Drug Release And Reduced Side Effects To Drive Adoption 83
Table 19 Multi-Layer Drug-In-Adhesive Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 84
6.3 Matrix Patches 85
6.3.1 Technological Advancements In New Matrix Materials To Support Market Growth 85
Table 20 Matrix Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 85
6.4 Reservoir Membrane Patches 86
6.4.1 Offer Great Control Over Drug Delivery Rates 86
Table 21 Reservoir Membrane Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 86
6.5 Microneedle Patches 87
6.5.1 Ability To Deliver Active Pharmaceutical Ingredients To Boost Adoption 87
Table 22 Microneedle Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 87
6.6 Iontophoresis Patches 88
6.6.1 Used To Deliver Medicines With Low Molecular Weight 88
Table 23 Iontophoresis Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 88
6.7 Vapor Patches 89
6.7.1 Release Essential Oils For Up To 6 Hours 89
Table 24 Vapor Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 89

7 Transdermal Patches Market, By Adhesive Type 90
7.1 Introduction 91
Table 25 Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 91
7.2 Acrylic Adhesives 91
7.2.1 High Durability To Boost Demand 91
Table 26 Transdermal Patches Market For Acrylic Adhesives, By Country, 2021–2029 (Usd Million) 92
7.3 Silicone Adhesives 92
7.3.1 Low Peel Adhesion Property Makes It Ideal For Medical Applications 92
Table 27 Transdermal Patches Market For Silicone Adhesives, By Country, 2021–2029 (Usd Million) 93
7.4 Hydrogel Adhesives 94
7.4.1 Increasing Demand For Transdermal Drug Delivery Systems To Drive Market 94
Table 28 Transdermal Patches Market For Hydrogel Adhesives, By Country, 2021–2029 (Usd Million) 94
7.5 Other Adhesives 95
Table 29 Transdermal Patches Market For Other Adhesives, By Country, 2021–2029 (Usd Million) 95

8 Transdermal Patches Market, By Application 96
8.1 Introduction 97
Table 30 Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 97
8.2 Pain Management 97
8.2.1 High Burden Of Chronic Pain Worldwide To Drive Market 97
Table 31 Transdermal Patches Available For Pain Management 98
Table 32 Transdermal Patches Market For Pain Management, By Country, 2021–2029 (Usd Million) 98
8.3 Smoking Cessation 99
8.3.1 Controlled Drug Delivery And Reduced Side Effects To Support Market Growth 99
Table 33 Transdermal Patches Available For Smoking Cessation 99
Table 34 Transdermal Patches Market For Smoking Cessation, By Country, 2021–2029 (Usd Million) 100
8.4 Hormone Replacement Therapy 100
Table 35 Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 101
Table 36 Transdermal Patches Market For Hormone Replacement Therapy, By Country, 2021–2029 (Usd Million) 101
8.4.1 Transdermal Testosterone Therapy 102
8.4.1.1 Increased Bone Density, Better Muscle Development, And Reduced Risk Factors To Support Market Growth 102
Table 37 Transdermal Patches Available For Transdermal Testosterone Therapy 102
Table 38 Transdermal Patches Market For Transdermal Testosterone Therapy, By Country, 2021–2029 (Usd Million) 102
8.4.2 Transdermal Estrogen Therapy 103
8.4.2.1 Growing Use Of Transdermal Contraceptive Patches To Drive Market 103
Table 39 Transdermal Patches Available For Transdermal Estrogen Therapy 103
Table 40 Transdermal Patches Market For Transdermal Estrogen Therapy, By Country, 2021–2029 (Usd Million) 104
8.5 Central Nervous System Disorders 104
8.5.1 Ease Of Use, Simple Treatment Regimen, And Continuous Delivery Of Drugs To Drive Adoption 104
Table 41 Transdermal Patches Available For Central Nervous System Disorders 105
Table 42 Transdermal Patches Market For Central Nervous System Disorders, By Country, 2021–2029 (Usd Million) 105
8.6 Cardiovascular Diseases 106
8.6.1 Availability Of Alternative And Advanced Drug Delivery Options To Limit Market Growth 106
Table 43 Transdermal Patches Available For Cardiovascular Diseases 106
Table 44 Transdermal Patches Market For Cardiovascular Diseases, By Country, 2021–2029 (Usd Million) 107
8.7 Other Applications 107
Table 45 Transdermal Patches Available For Other Applications 108
Table 46 Transdermal Patches Market For Other Applications, By Country, 2021–2029 (Usd Million) 108

9 Transdermal Patches Market, By Distribution Channel 109
9.1 Introduction 110
Table 47 Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 110
9.2 Hospital Pharmacies 110
9.2.1 Largest Distribution Channel For Transdermal Patches 110
Table 48 Transdermal Patches Market For Hospital Pharmacies, By Country, 2021–2029 (Usd Million) 111
9.3 Retail Pharmacies 111
9.3.1 Improving Healthcare Infrastructure To Drive Market 111
Table 49 Transdermal Patches Market For Retail Pharmacies, By Country, 2021–2029 (Usd Million) 112
9.4 Online Pharmacies 112
9.4.1 Fastest-Growing Segment Due To Easy Accessibility To Medications 112
Table 50 Transdermal Patches Market For Online Pharmacies, By Country, 2021–2029 (Usd Million) 113

10 Transdermal Patches Market, By End User 114
10.1 Introduction 115
Table 51 Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 115
10.2 Home Care Settings 115
10.2.1 Rapid Growth In Geriatric Population To Support Market Growth 115
Table 52 Transdermal Patches Market For Home Care Settings, By Country, 2021–2029 (Usd Million) 116
10.3 Hospitals & Clinics 117
10.3.1 Increasing Prevalence Of Chronic Diseases To Drive Market 117
Table 53 Transdermal Patches Market For Hospitals & Clinics, By Country, 2021–2029 (Usd Million) 118

11 Transdermal Patches Market, By Region 119
11.1 Introduction 120
Table 54 Transdermal Patches Market, By Region, 2021–2029 (Usd Million) 120
11.2 North America 121
11.2.1 Impact Of Recession On North American Transdermal Patches Market 121
Figure 36 North America: Transdermal Patches Market Snapshot 122
Table 55 North America: Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 123
Table 56 North America: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 123
Table 57 North America: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 124
Table 58 North America: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 124
Table 59 North America: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 125
Table 60 North America: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 125
Table 61 North America: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 126
Table 62 North America: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 126
11.2.2 Us 126
11.2.2.1 Largest Market For Transdermal Patches 126
Table 63 Us: Macroeconomic Indicators 127
Table 64 Us: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 127
Table 65 Us: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 128
Table 66 Us: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 128
Table 67 Us: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 129
Table 68 Us: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 129
Table 69 Us: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 130
Table 70 Us: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 130
11.2.3 Canada 130
11.2.3.1 Rising Funding For Transdermal Drug Delivery Research To Drive Market 130
Table 71 Canada: Macroeconomic Indicators 131
Table 72 Canada: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 131
Table 73 Canada: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 131
Table 74 Canada: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 132
Table 75 Canada: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 132
Table 76 Canada: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 133
Table 77 Canada: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 133
Table 78 Canada: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 133
11.3 Europe 134
11.3.1 Impact Of Recession On European Transdermal Patches Market 134
Table 79 Europe: Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 135
Table 80 Europe: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 135
Table 81 Europe: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 136
Table 82 Europe: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 136
Table 83 Europe: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 137
Table 84 Europe: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 137
Table 85 Europe: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 138
Table 86 Europe: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 138
11.3.2 Germany 138
11.3.2.1 Favorable Government Policies To Aid Market Growth 138
Table 87 Germany: Macroeconomic Indicators 139
Table 88 Germany: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 139
Table 89 Germany: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 140
Table 90 Germany: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 140
Table 91 Germany: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 141
Table 92 Germany: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 141
Table 93 Germany: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 142
Table 94 Germany: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 142
11.3.3 Uk 142
11.3.3.1 Increasing Funding For R&D Of Innovative Transdermal Technologies To Drive Market 142
Table 95 Uk: Macroeconomic Indicators 143
Table 96 Uk: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 143
Table 97 Uk: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 143
Table 98 Uk: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 144
Table 99 Uk: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 144
Table 100 Uk: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 144
Table 101 Uk: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 145
Table 102 Uk: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 145
11.3.4 France 145
11.3.4.1 Development Of Transdermal Drug Delivery Systems By Local Players To Support Market Growth 145
Table 103 France: Macroeconomic Indicators 146
Table 104 France: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 146
Table 105 France: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 147
Table 106 France: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 147
Table 107 France: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 148
Table 108 France: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 148
Table 109 France: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 149
Table 110 France: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 149
11.3.5 Italy 149
11.3.5.1 High Burden Of Lung Cancer To Propel Market 149
Table 111 Italy: Macroeconomic Indicators 150
Table 112 Italy: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 150
Table 113 Italy: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 150
Table 114 Italy: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 151
Table 115 Italy: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 151
Table 116 Italy: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 151
Table 117 Italy: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 152
Table 118 Italy: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 152
11.3.6 Spain 152
11.3.6.1 Growing Demand For Self-Care And Personalized Medicine To Drive Market 152
Table 119 Spain: Macroeconomic Indicators 153
Table 120 Spain: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 153
Table 121 Spain: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 153
Table 122 Spain: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 154
Table 123 Spain: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 154
Table 124 Spain: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 155
Table 125 Spain: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 155
Table 126 Spain: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 155
11.3.7 Rest Of Europe 156
Table 127 Rest Of Europe: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 156
Table 128 Rest Of Europe: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 156
Table 129 Rest Of Europe: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 157
Table 130 Rest Of Europe: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 157
Table 131 Rest Of Europe: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 158
Table 132 Rest Of Europe: Transdermal Patches Market, By Distribution Channel 2021–2029 (Usd Million) 158
Table 133 Rest Of Europe: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 158
11.4 Asia Pacific 159
11.4.1 Impact Of Recession On Asia Pacific Transdermal Patches Market 159
Figure 37 Asia Pacific: Transdermal Patches Market Snapshot 160
Table 134 Asia Pacific: Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 161
Table 135 Asia Pacific: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 161
Table 136 Asia Pacific: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 162
Table 137 Asia Pacific: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 162
Table 138 Asia Pacific: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 163
Table 139 Asia Pacific: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 163
Table 140 Asia Pacific: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 164
Table 141 Asia Pacific: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 164
11.4.2 China 164
11.4.2.1 Large Diabetic Population To Drive Market 164
Table 142 China: Macroeconomic Indicators 165
Table 143 China: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 165
Table 144 China: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 166
Table 145 China: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 166
Table 146 China: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 167
Table 147 China: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 167
Table 148 China: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 167
Table 149 China: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 168
11.4.3 Japan 168
11.4.3.1 Increasing Number Of Product Approvals And Growing Focus Of Local Players On R&D Of Transdermal Systems To Support Market Growth 168
Table 150 Japan: Macroeconomic Indicators 168
Table 151 Japan: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 169
Table 152 Japan: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 169
Table 153 Japan: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 170
Table 154 Japan: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 170
Table 155 Japan: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 171
Table 156 Japan: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 171
Table 157 Japan: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 171
11.4.4 India 172
11.4.4.1 Increasing Focus On Noninvasive Methods Of Drug Delivery To Drive Market 172
Table 158 India: Macroeconomic Indicators 172
Table 159 India: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 172
Table 160 India: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 173
Table 161 India: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 173
Table 162 India: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 174
Table 163 India: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 174
Table 164 India: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 174
Table 165 India: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 175
11.4.5 South Korea 175
11.4.5.1 Rising Healthcare Spending And Increasing Government Initiatives To Propel Market 175
Table 166 South Korea: Macroeconomic Indicators 175
Table 167 South Korea: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 176
Table 168 South Korea: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 176
Table 169 South Korea: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 177
Table 170 South Korea: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 177
Table 171 South Korea: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 178
Table 172 South Korea: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 178
Table 173 South Korea: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 178
11.4.6 Australia 179
11.4.6.1 Increasing Number Of Smokers To Drive Market 179
Table 174 Australia: Macroeconomic Indicators 179
Table 175 Australia: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 179
Table 176 Australia: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 180
Table 177 Australia: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 180
Table 178 Australia: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 181
Table 179 Australia: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 181
Table 180 Australia: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 182
Table 181 Australia: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 182
11.4.7 Rest Of Asia Pacific 182
Table 182 Rest Of Asia Pacific: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 183
Table 183 Rest Of Asia Pacific: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 183
Table 184 Rest Of Asia Pacific: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 184
Table 185 Rest Of Asia Pacific: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 184
Table 186 Rest Of Asia Pacific: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 185
Table 187 Rest Of Asia Pacific: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 185
Table 188 Rest Of Asia Pacific: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 185
11.5 Latin America 186
11.5.1 Impact Of Recession On Transdermal Patches Market In Latin America 186
Table 189 Latin America: Transdermal Patches Market, By Country, 2021–2029 (Usd Million) 186
Table 190 Latin America: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 187
Table 191 Latin America: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 187
Table 192 Latin America: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 188
Table 193 Latin America: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 188
Table 194 Latin America: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 189
Table 195 Latin America: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 189
Table 196 Latin America: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 189
11.5.2 Brazil 190
11.5.2.1 High Prevalence Of Diabetes To Propel Market 190
Table 197 Brazil: Key Macroindicators 190
Table 198 Brazil: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 190
Table 199 Brazil: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 191
Table 200 Brazil: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 191
Table 201 Brazil: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 191
Table 202 Brazil: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 192
Table 203 Brazil: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 192
Table 204 Brazil: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 192
11.5.3 Mexico 193
11.5.3.1 Government Investments To Drive Transdermal Drug Delivery Production 193
Table 205 Mexico: Key Macroindicators 193
Table 206 Mexico: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 193
Table 207 Mexico: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 194
Table 208 Mexico: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 194
Table 209 Mexico: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 195
Table 210 Mexico: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 195
Table 211 Mexico: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 196
Table 212 Mexico: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 196
11.5.4 Rest Of Latin America 196
Table 213 Rest Of Latin America: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 197
Table 214 Rest Of Latin America: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 197
Table 215 Rest Of Latin America: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 198
Table 216 Rest Of Latin America: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 198
Table 217 Rest Of Latin America: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 199
Table 218 Rest Of Latin America: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 199
Table 219 Rest Of Latin America: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 199
11.6 Middle East & Africa 200
11.6.1 Government Support To Boost Local Production To Offer Growth Opportunities For Transdermal Patch Manufacturers 200
11.6.2 Impact Of Recession On Transdermal Patches Market In Middle East And Africa 200
Table 220 Middle East & Africa: Transdermal Patches Market, By Patch Type, 2021–2029 (Usd Million) 201
Table 221 Middle East & Africa: Drug-In-Adhesive Transdermal Patches Market, By Type, 2021–2029 (Usd Million) 201
Table 222 Middle East & Africa: Transdermal Patches Market, By Adhesive Type, 2021–2029 (Usd Million) 202
Table 223 Middle East & Africa: Transdermal Patches Market, By Application, 2021–2029 (Usd Million) 202
Table 224 Middle East & Africa: Transdermal Patches Market For Hormone Replacement Therapy, By Type, 2021–2029 (Usd Million) 203
Table 225 Middle East & Africa: Transdermal Patches Market, By Distribution Channel, 2021–2029 (Usd Million) 203
Table 226 Middle East & Africa: Transdermal Patches Market, By End User, 2021–2029 (Usd Million) 203

12 Competitive Landscape 204
12.1 Introduction 204
Table 227 Key Developments In Transdermal Patches Market (January 2020–October 2023) 204
12.2 Revenue Analysis Of Key Market Players 205
Figure 38 Revenue Analysis Of Key Players In Transdermal Patches Market 205
12.3 Market Share Analysis 206
Figure 39 Transdermal Patches Market Share, By Key Player, 2022 206
12.4 Company Footprint 207
12.4.1 Footprint Of Companies In Transdermal Patches Market 207
12.4.2 Patch Type Footprint 208
12.4.3 Adhesive Type Footprint 209
12.4.4 Application Footprint 210
12.4.5 Distribution Channel Footprint 211
12.4.6 End-User Footprint 212
12.4.7 Regional Footprint 213
12.5 Transdermal Patches Market: R&D Expenditure 214
Figure 40 R&D Expenditure Of Key Players In Transdermal Patches Market (2021 Vs. 2022) 214
12.6 Company Evaluation Matrix 215
12.6.1 Stars 215
12.6.2 Emerging Leaders 215
12.6.3 Pervasive Players 215
12.6.4 Participants 215
Figure 41 Transdermal Patches Market: Company Evaluation Matrix, 2022 216
12.7 Sme/Startup Evaluation Matrix 216
12.7.1 Progressive Companies 216
12.7.2 Starting Blocks 216
12.7.3 Responsive Companies 217
12.7.4 Dynamic Companies 217
Figure 42 Transdermal Patches Market: Sme/Startup Evaluation Matrix 217
12.7.5 Competitive Benchmarking 218
Table 228 Transdermal Patches Market: Detailed List Of Key Startup/Smes 218
12.8 Competitive Situation And Trends 218
12.8.1 Product Launches 218
Table 229 Transdermal Patches Market: Product Launches, January 2020–October 2023 218
12.8.2 Deals 219
Table 230 Transdermal Patches Market: Deals, January 2020–October 2023 219
12.8.3 Other Developments 220
Table 231 Transdermal Patches Market: Other Developments, January 2020–October 2023 220

13 Company Profiles 221
(Business Overview, Products Offered, Recent Developments & Mnm View)*
13.1 Key Players 221
13.1.1 Hisamitsu Pharmaceutical Co., Inc. 221
Table 232 Hisamitsu Pharmaceutical Co., Inc.: Business Overview 221
Figure 43 Hisamitsu Pharmaceutical Co., Inc.: Company Snapshot (2022) 222
13.1.2 Viatris Inc. 225
Table 233 Viatris Inc.: Business Overview 225
Figure 44 Viatris Inc.: Company Snapshot (2022) 226
13.1.3 Novartis Ag 229
Table 234 Novartis Ag: Business Overview 229
Figure 45 Novartis Ag: Company Snapshot (2022) 230
13.1.4 Boehringer Ingelheim International Gmbh 232
Table 235 Boehringer Ingelheim International Gmbh: Business Overview 232
Figure 46 Boehringer Ingelheim International Gmbh: Company Snapshot (2022) 233
13.1.5 Johnson & Johnson 235
Table 236 Johnson & Johnson: Business Overview 235
Figure 47 Johnson & Johnson: Company Snapshot (2022) 236
13.1.6 Ucb S.A. 238
Table 237 Ucb S.A.: Business Overview 238
Figure 48 Ucb S.A.: Company Snapshot (2022) 238
13.1.7 Endo International Plc 240
Table 238 Endo International Plc: Business Overview 240
Figure 49 Endo International Plc: Company Snapshot (2022) 240
13.1.8 Luye Pharma Group 242
Table 239 Luye Pharma Group: Business Overview 242
Figure 50 Luye Pharma Group: Company Snapshot (2022) 242
13.1.9 Abbvie Inc. 244
Table 240 Abbvie Inc.: Business Overview 244
Figure 51 Abbvie Inc.: Company Snapshot (2022) 245
13.1.10 Nitto Denko Corporation 247
Table 241 Nitto Denko Corporation: Business Overview 247
Figure 52 Nitto Denko Corporation: Company Snapshot (2022) 247
13.1.11 Cipla Inc. 249
Table 242 Cipla Inc.: Business Overview 249
Figure 53 Cipla Inc.: Company Snapshot (2022) 249
13.1.12 Teva Pharmaceutical Industries Ltd. 251
Table 243 Teva Pharmaceutical Industries Ltd.: Business Overview 251
Figure 54 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2022) 251
13.1.13 Agile Therapeutics 253
Table 244 Agile Therapeutics: Business Overview 253
Figure 55 Agile Therapeutics: Company Snapshot (2022) 253
13.1.14 Bayer Ag 255
Table 245 Bayer Ag: Business Overview 255
Figure 56 Bayer Ag: Company Snapshot (2022) 256
13.1.15 Amneal Pharmaceuticals Llc 258
Table 246 Amneal Pharmaceuticals Llc: Business Overview 258
Figure 57 Amneal Pharmaceuticals Llc: Company Snapshot (2022) 258
13.1.16 Hikma Pharmaceuticals Plc 260
Table 247 Hikma Pharmaceuticals Plc: Business Overview 260
Figure 58 Hikma Pharmaceuticals Plc: Company Snapshot (2022) 260
*Details On Business Overview, Products Offered, Recent Developments & Mnm View Might Not Be Captured In Case Of Unlisted Companies.
13.2 Other Players 262
13.2.1 Alvogen Group Inc. 262
Table 248 Alvogen Group Inc.: Company Overview 262
13.2.2 Sparsha Pharma International Pvt. Ltd. 262
Table 249 Sparsha Pharma International Pvt. Ltd.: Company Overview 262
13.2.3 Iontopatch 263
Table 250 Iontopatch: Company Overview 263
13.2.4 Medherant Limited 263
Table 251 Medherant Limited: Company Overview 263
13.2.5 Adhexpharma 264
Table 252 Adhexpharma: Company Overview 264
13.2.6 Evernow 264
Table 253 Evernow: Company Overview 264
13.2.7 Lead Chemical Co., Ltd. 265
Table 254 Lead Chemical Co., Ltd.: Company Overview 265
13.2.8 Purdue Pharma L.P. 265
Table 255 Purdue Pharma L.P.: Company Overview 265
13.2.9 Mundipharma International 266
Table 256 Mundipharma International: Company Overview 266
13.3 Companies Providing Adhesives For Transdermal Patches 267
13.3.1 Wacker Chemie Ag 267
13.3.1.1 Business Overview 267
Table 257 Wacker Chemie Ag: Business Overview 267
Figure 59 Wacker Chemie Ag: Company Snapshot (2022) 268
13.3.1.2 Products Offered 268
13.3.2 Elkem Asa 269
13.3.2.1 Business Overview 269
Table 258 Elkem Asa: Business Overview 269
Figure 60 Elkem Asa: Company Snapshot (2022) 270
13.3.2.2 Products Offered 270
13.3.3 Dupont De Nemours, Inc. 271
13.3.3.1 Business Overview 271
Table 259 Dupont De Nemours, Inc.: Business Overview 271
Figure 61 Dupont De Nemours, Inc.: Company Snapshot (2022) 272
13.3.3.2 Products Offered 272
13.3.4 Katecho, Llc 273
Table 260 Katecho, Llc: Company Overview 273
13.3.5 Polymer Science, Inc. 273
Table 261 Polymer Science, Inc.: Company Overview 273

14 Appendix 274
14.1 Discussion Guide 274
14.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 278
14.3 Customization Options 280
14.4 Related Reports 280
14.5 Author Details 281

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs